Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Pre-Tax Income 2011-2024 | ZTS

Zoetis annual/quarterly pre-tax income history and growth rate from 2011 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
  • Zoetis pre-tax income for the quarter ending September 30, 2024 was $0.874B, a 21.9% increase year-over-year.
  • Zoetis pre-tax income for the twelve months ending September 30, 2024 was $3.051B, a 6.01% increase year-over-year.
  • Zoetis annual pre-tax income for 2023 was $2.936B, a 10.54% increase from 2022.
  • Zoetis annual pre-tax income for 2022 was $2.656B, a 6.75% increase from 2021.
  • Zoetis annual pre-tax income for 2021 was $2.488B, a 24.65% increase from 2020.
  
Zoetis Annual Pre-Tax Income
(Millions of US $)
2023 $2,936
2022 $2,656
2021 $2,488
2020 $1,996
2019 $1,801
2018 $1,690
2017 $1,525
2016 $1,228
2015 $545
2014 $820
2013 $690
2012 $710
2011 $394
2010 $178
Zoetis Quarterly Pre-Tax Income
(Millions of US $)
2024-09-30 $874
2024-06-30 $780
2024-03-31 $747
2023-12-31 $650
2023-09-30 $717
2023-06-30 $872
2023-03-31 $697
2022-12-31 $592
2022-09-30 $667
2022-06-30 $670
2022-03-31 $727
2021-12-31 $506
2021-09-30 $659
2021-06-30 $636
2021-03-31 $687
2020-12-31 $420
2020-09-30 $597
2020-06-30 $482
2020-03-31 $497
2019-12-31 $437
2019-09-30 $528
2019-06-30 $455
2019-03-31 $381
2018-12-31 $418
2018-09-30 $418
2018-06-30 $437
2018-03-31 $417
2017-12-31 $430
2017-09-30 $413
2017-06-30 $345
2017-03-31 $337
2016-12-31 $231
2016-09-30 $333
2016-06-30 $332
2016-03-31 $332
2015-12-31 $69
2015-09-30 $273
2015-06-30 $-27
2015-03-31 $230
2014-12-31 $155
2014-09-30 $238
2014-06-30 $200
2014-03-31 $227
2013-12-31 $126
2013-09-30 $185
2013-06-30 $187
2013-03-31 $192
2012-12-31 $74
2012-09-30 $213
2012-06-30 $252
2012-03-31 $171
2011-12-31
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $79.838B $8.544B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $42.573B 8.86
Sandoz Group AG (SDZNY) Switzerland $19.533B 0.00
Merck (MKKGY) Germany $19.083B 17.09
Astellas Pharma (ALPMY) Japan $18.260B 16.82
United Therapeutics (UTHR) United States $16.648B 16.38
Summit Therapeutics (SMMT) United States $14.012B 0.00
Neurocrine Biosciences (NBIX) United States $12.722B 33.69
Shionogi (SGIOY) Japan $12.010B 11.51
Catalent (CTLT) United States $11.069B 0.00
Madrigal Pharmaceuticals (MDGL) United States $7.578B 0.00
Orion OYJ (ORINY) Finland $6.653B 18.71
Corcept Therapeutics (CORT) United States $6.029B 45.67
Ionis Pharmaceuticals (IONS) United States $5.370B 0.00
Crinetics Pharmaceuticals (CRNX) United States $5.199B 0.00
PTC Therapeutics (PTCT) United States $3.334B 0.00
Dyne Therapeutics (DYN) United States $3.021B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.600B 15.54
Catalyst Pharmaceuticals (CPRX) United States $2.562B 11.61
Soleno Therapeutics (SLNO) United States $2.491B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $2.247B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.866B 0.00
Xencor (XNCR) United States $1.750B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.634B 0.00
Evotec AG (EVO) Germany $1.591B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.574B 0.00
Harrow (HROW) United States $1.528B 0.00
Indivior (INDV) United States $1.500B 6.11
Guardian Pharmacy Services (GRDN) United States $1.461B 0.00
Ocular Therapeutix (OCUL) United States $1.388B 0.00
ARS Pharmaceuticals (SPRY) United States $1.361B 0.00
Cassava Sciences (SAVA) United States $1.274B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.269B 0.00
Ardelyx (ARDX) United States $1.258B 0.00
Enliven Therapeutics (ELVN) United States $1.199B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.124B 0.00
Collegium Pharmaceutical (COLL) United States $0.966B 5.27
Bioventus (BVS) United States $0.950B 30.03
Cronos Group (CRON) Canada $0.795B 0.00
Relay Therapeutics (RLAY) United States $0.795B 0.00
USANA Health Sciences (USNA) United States $0.760B 14.10
Oruka Therapeutics (ORKA) United States $0.726B 0.00
Elite Pharmaceuticals (ELTP) United States $0.659B 0.00
Altimmune (ALT) United States $0.617B 0.00
Tourmaline Bio (TRML) United States $0.590B 0.00
Savara (SVRA) United States $0.577B 0.00
OmniAb (OABI) United States $0.554B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.551B 0.00
Organogenesis (ORGO) United States $0.537B 0.00
Zevra Therapeutics (ZVRA) United States $0.512B 0.00
Esperion Therapeutics (ESPR) United States $0.497B 0.00
ProKidney (PROK) United States $0.493B 0.00
Korro Bio (KRRO) United States $0.490B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.466B 0.00
Siga Technologies (SIGA) United States $0.463B 5.40
Xeris Biopharma Holdings (XERS) United States $0.461B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.459B 186.00
KalVista Pharmaceuticals (KALV) United States $0.439B 0.00
Aquestive Therapeutics (AQST) United States $0.416B 0.00
Verve Therapeutics (VERV) United States $0.411B 0.00
Akebia Therapeutics (AKBA) United States $0.410B 0.00
Larimar Therapeutics (LRMR) United States $0.393B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.361B 0.00
4D Molecular Therapeutics (FDMT) United States $0.360B 0.00
Avita Medical (RCEL) United States $0.350B 0.00
Sage Therapeutics (SAGE) United States $0.316B 0.00
Nature's Sunshine Products (NATR) United States $0.296B 17.58
Aldeyra Therapeutics (ALDX) United States $0.289B 0.00
Aclaris Therapeutics (ACRS) United States $0.271B 0.00
Lyell Immunopharma (LYEL) United States $0.265B 0.00
Lexeo Therapeutics (LXEO) United States $0.214B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.213B 0.00
Silence Therapeutics (SLN) United Kingdom $0.210B 0.00
Acrivon Therapeutics (ACRV) United States $0.204B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.198B 0.00
Nektar Therapeutics (NKTR) United States $0.194B 0.00
Profound Medical (PROF) Canada $0.186B 0.00
Nanobiotix S.A (NBTX) France $0.179B 0.00
MediWound (MDWD) Israel $0.178B 0.00
Galectin Therapeutics (GALT) United States $0.174B 0.00
Heron Therapeutics (HRTX) United States $0.163B 0.00
Inhibikase Therapeutics (IKT) United States $0.155B 0.00
Achieve Life Sciences (ACHV) Canada $0.148B 0.00
CytoDyn (CYDY) United States $0.140B 0.00
VAXART, INC (VXRT) United States $0.136B 0.00
Cardiol Therapeutics (CRDL) Canada $0.132B 0.00
Telomir Pharmaceuticals (TELO) United States $0.126B 0.00
Pyxis Oncology (PYXS) United States $0.113B 0.00
Journey Medical (DERM) United States $0.112B 0.00
Karyopharm Therapeutics (KPTI) United States $0.106B 0.00
Avalo Therapeutics (AVTX) United States $0.105B 0.00
Context Therapeutics (CNTX) United States $0.104B 0.00
Century Therapeutics (IPSC) United States $0.103B 0.00
Innate Pharma SA (IPHYF) France $0.103B 0.00
Fractyl Health (GUTS) United States $0.101B 0.00
Regulus Therapeutics (RGLS) United States $0.096B 0.00
Inotiv (NOTV) United States $0.093B 0.00
Assertio Holdings (ASRT) United States $0.090B 23.52
Arch Biopartners (ACHFF) Canada $0.090B 0.00
Relmada Therapeutics (RLMD) United States $0.084B 0.00
PMV Pharmaceuticals (PMVP) United States $0.083B 0.00
ESSA Pharma (EPIX) Canada $0.081B 0.00
Vivani Medical (VANI) United States $0.079B 0.00
CASI Pharmaceuticals (CASI) China $0.079B 0.00
Swiftmerge Acquisition (IVCP) United States $0.076B 0.00
ElectroCore (ECOR) United States $0.073B 0.00
OptiNose (OPTN) United States $0.072B 0.00
Metagenomi (MGX) United States $0.071B 0.00
Scienture Holdings (SCNX) United States $0.065B 0.00
AlloVir (ALVR) United States $0.064B 0.00
Champions Oncology (CSBR) United States $0.062B 0.00
Mural Oncology (MURA) Ireland $0.057B 0.00
Unicycive Therapeutics (UNCY) United States $0.055B 0.00
BioVie (BIVI) United States $0.054B 0.00
Nutriband (NTRB) United States $0.053B 0.00
Prelude Therapeutics (PRLD) United States $0.052B 0.00
Iterum Therapeutics (ITRM) Ireland $0.050B 0.00
Protara Therapeutics (TARA) United States $0.049B 0.00
Rafael Holdings (RFL) United States $0.047B 0.00
Gain Therapeutics (GANX) United States $0.046B 0.00
SCYNEXIS (SCYX) United States $0.046B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.045B 0.00
VYNE Therapeutics (VYNE) United States $0.045B 0.00
FibroGen (FGEN) United States $0.040B 0.00
Tempest Therapeutics (TPST) United States $0.040B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.038B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.036B 0.00
Incannex Healthcare (IXHL) Australia $0.035B 0.00
Carisma Therapeutics (CARM) United States $0.034B 0.00
CERo Therapeutics Holdings (CERO) United States $0.033B 0.00
DURECT (DRRX) United States $0.031B 0.00
Surrozen (SRZN) United States $0.030B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.028B 0.00
Lipocine (LPCN) United States $0.028B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
Citius Pharmaceuticals (CTXR) United States $0.024B 0.00
BioLineRx (BLRX) Israel $0.022B 0.00
GlycoMimetics (GLYC) United States $0.020B 0.00
Enlivex Therapeutics (ENLV) Israel $0.020B 0.00
MEI Pharma (MEIP) United States $0.019B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.018B 0.00
Cosmos Health (COSM) United States $0.017B 0.00
PolyPid (PYPD) Israel $0.017B 0.00
Mannatech (MTEX) United States $0.016B 0.00
TherapeuticsMD (TXMD) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
Vivos Therapeutics (VVOS) United States $0.015B 0.00
NRx Pharmaceuticals (NRXP) United States $0.015B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.015B 0.00
Traws Pharma (TRAW) United States $0.014B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.013B 0.00
Nuvilex (PMCB) United States $0.013B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Jaguar Animal Health (JAGX) United States $0.012B 0.00
Talphera (TLPH) United States $0.012B 0.00
Conduit Pharmaceuticals (CDT) United States $0.011B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.010B 0.00
Indaptus Therapeutics (INDP) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Dominari Holdings (DOMH) United States $0.010B 0.00
Redhill Biopharma (RDHL) Israel $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Klotho Neurosciences (KLTO) United States $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Viracta Therapeutics (VIRX) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Biomerica (BMRA) United States $0.005B 0.00
Aditxt (ADTX) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.11
Aptorum Group (APM) United Kingdom $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
TNF Pharmaceuticals (TNFA) United States $0.004B 0.00
Qualigen Therapeutics (QLGN) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
Oncternal Therapeutics (ONCT) United States $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Molecular Templates (MTEM) United States $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
PainReform (PRFX) Israel $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 1.77
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 38.53